attach
follow
redistribut
cap
viru
particl
cell
surfac
may
play
role
uptak
process
certain
virus
penetr
plasma
membran
directli
mani
envelop
nonenvelop
virus
endocytos
coat
pit
subsequ
pass
endosom
low
ph
environ
endosom
facilit
passag
viral
genom
cytoplasm
virus
mechan
membran
penetr
known
link
phmediat
conform
chang
extern
virion
protein
consequ
infect
alter
permeabd
plasma
membran
may
contribut
cellular
damag
recent
advanc
understand
proteg
review
relev
ti
develop
new
strategi
vaccin
emphasis
past
seven
year
seen
upsurg
interest
earli
viru
cell
interact
evid
recent
review
subject
even
littl
known
precis
term
molecular
detail
interact
anim
virus
host
cell
receptor
howev
advent
rapid
sequenc
viru
glycoprotein
involv
interact
knowledg
process
quickli
expand
seem
opportun
moment
therefor
reapprais
biolog
data
present
time
review
concentr
well
studi
virus
hope
illustr
gener
mechan
involv
whilst
time
emphasis
specif
detail
may
appli
univers
even
genet
close
relat
virus
possibl
also
emphas
practic
applic
detail
viruscel
interact
may
cellular
attach
uptak
viru
depend
presenc
specif
cell
surfac
structur
recognis
virion
attach
protein
cell
surfac
receptor
may
restrict
singl
speci
plasma
membran
receptor
probabl
case
adenoviru
epsteinbarr
viru
hand
recognit
structur
may
ubiquit
distribut
sialic
acid
exampl
essenti
compon
cell
surfac
receptor
influenza
paramyxo
polyoma
encephalomyocard
virus
sinc
heterogen
array
glycoprotein
glycolipid
contain
residu
number
potenti
receptor
molecul
larg
nevertheless
virus
exhibit
strict
vari
specif
precis
sialyloligosaccharid
sequenc
recognis
well
character
viru
receptor
glycophorin
sialoglycoprotein
bind
site
influenza
viru
erythrocyt
receptor
adenoviru
type
hela
cell
identifi
kdalton
glycoprotein
less
well
defin
receptor
semliki
forest
viru
sfv
histocompat
antigen
report
associ
sfv
bind
site
howev
sinc
viru
attach
grow
mhc
neg
cell
line
glycoprotein
may
involv
noninfecti
adsorpt
latter
context
interest
note
footandmouth
diseas
viru
fmdv
appear
requir
specif
receptor
site
bind
bhk
cell
although
interact
specif
cell
membran
molecul
may
still
requir
subsequ
intern
uncoat
membran
lipid
may
serv
receptor
bind
site
lipid
complex
lipid
sialicacidcontain
glycolipid
gangliosid
occur
natur
plasma
membran
cell
act
receptor
cholera
toxin
interferon
glycoprotein
hormon
well
certain
virus
cours
gangliosid
glycoprotein
may
involv
adsorpt
sinc
virion
approach
cell
would
interact
glycoprotein
first
make
intim
contact
plasma
membran
contain
gangliosid
thu
arbovirus
may
interact
specif
phosphatidylinositol
polyphosphoinositid
sfv
infect
inhibit
treatment
host
cell
phospholipas
c
interest
approach
investig
biochem
natur
bind
site
solubil
membran
constitu
cell
determin
compon
bind
viru
henc
inhibit
bind
cell
schlegel
et
al
u
carri
detail
studi
vesicular
stomat
viru
vsv
work
may
use
illustr
gener
principl
phosphatidylserin
ps
inhibit
vsv
plaqu
format
wherea
herp
viru
plaqu
format
unaffect
moreov
pscontain
liposom
bind
vsv
suggest
ps
function
bind
site
viru
vsv
presum
interact
hydrophil
polar
head
region
ps
sinc
domain
face
extern
environ
specif
bind
vsv
ps
like
mediat
viru
g
protein
sinc
amino
acid
sequenc
known
possibl
defin
precis
region
protein
respons
bind
g
proteinp
bind
almost
certainli
involv
simpl
ionic
interact
otherwis
anion
phospholipid
would
inhibit
vsv
bind
final
possibl
ps
role
promot
intern
membran
fusion
event
viru
g
protein
membran
acidifi
endosom
introductori
remark
point
although
gener
observ
may
made
pertain
earli
viru
cell
interact
specif
detail
differ
virus
even
genet
relat
virus
may
illustr
work
carrol
et
al
ls
describ
differ
adsorpt
properti
influenza
ri
virus
erythrocyt
attribut
differ
sialyloligosaccharid
receptor
specif
erythrocyt
treat
vibrio
cholera
neuraminidas
remov
sialic
acid
modifi
cmpneuac
three
purifi
sialyltransferas
contain
either
linkag
cell
surfac
glycoprotein
two
virus
total
differ
specif
bind
respect
linkag
similarli
derivat
erythrocyt
use
studi
receptor
specif
human
influenza
isol
select
presenc
either
hors
serum
guineapig
serum
rich
glycoprotein
contain
linkag
receptor
bind
specif
variant
chang
specif
parent
viru
either
specif
linkag
type
recognis
ha
gene
virus
sequenc
alter
receptor
bind
specif
shown
due
amino
acid
substitut
posit
v
lie
base
propos
receptorbind
pocket
pocket
peripheri
three
major
antigen
site
ha
b
see
figur
antigen
analys
differ
receptor
bind
specif
show
antihaemagglutinin
monoclon
antibodi
rais
viru
react
equal
well
variant
small
number
fail
react
viru
studi
demonstr
hostspecifi
sialyloligosaccharid
exert
select
pressur
influenza
virus
agreement
known
influenza
virus
isol
equin
avian
sourc
natur
select
procedur
demonstr
shown
vari
influenza
variant
avian
human
origin
wherea
human
isol
either
stabl
grown
either
mdckcultur
egg
avian
variant
stabl
mdckcultur
revert
spontan
passag
egg
revers
shown
involv
amino
acid
substitut
posit
concurr
describ
select
subpopul
influenza
b
virus
cultiv
viru
mdck
cell
embryon
hen
egg
latter
host
system
clone
popul
virion
differ
antigen
composit
detect
monoclon
polyclon
antibodi
compar
parent
viru
cultiv
mdck
cell
novel
implic
nonimmun
select
mechan
involv
host
cell
receptor
site
may
oper
select
gener
antigen
variant
influenza
viru
thu
contribut
toward
antigen
drift
evolut
viru
sinc
egg
routin
employ
prepar
influenza
vaccin
find
import
practic
implic
vaccin
design
efficaci
tabl
show
haemagglutinationinhibit
hi
reaction
four
influenza
b
virus
repres
strain
isol
passag
egg
mdck
cell
specimen
collect
school
outbreak
influenza
viru
prepar
test
antiha
monoclon
antibodi
prepar
influenza
b
viru
cultiv
egg
mdck
cell
shown
tabl
three
pattern
serolog
reactiv
discern
monoclon
antibodi
react
high
titr
influenza
b
virus
test
monoclon
antibodi
react
virus
isol
subsequ
passag
mdck
cultur
none
virus
cultiv
egg
stage
passag
histori
antibodi
react
virus
least
one
passag
egg
none
virus
passag
mcdk
cultur
mutual
exclus
natur
reaction
antibodi
viru
prepar
test
strike
virus
differ
passag
histori
egg
cell
cultur
would
expect
react
differ
monoclon
antibodi
direct
antigen
present
carbohydr
moieti
deriv
host
cell
membran
coval
link
haemagglutinin
molecul
howev
explan
find
none
monoclon
antibodi
gave
hi
reaction
entir
determin
last
cultur
system
test
viru
grown
moreov
reaction
influenza
b
specif
affect
absorb
antibodi
homogen
chorioallanto
membran
mdck
cell
experi
investig
biolog
differ
antigen
distinct
subpopul
rang
erythrocyt
agglutin
virus
compar
erythrocyt
may
use
model
cellreceptor
specif
influenza
viru
tabl
test
erythrocyt
chicken
turkey
man
group
ab
cell
rhesu
monkey
guineapig
sheep
rat
hors
virus
irrespect
passag
histori
agglutin
cell
speci
similar
titr
except
sheep
hors
rat
erythrocyt
cell
latter
three
speci
high
agglutin
titr
detect
viru
isol
passag
egg
agglutin
detect
viru
passag
mdck
cultur
find
provid
strong
evid
influenza
b
viru
isol
clinic
specimen
grown
mdck
cultur
compris
least
two
biolog
antigen
distinct
subpopul
minor
proport
mdckgrown
viru
capabl
growth
allantoi
fertil
egg
without
prior
adapt
possess
ha
antigen
distinct
major
viru
grow
poorli
allanto
caviti
molecular
basi
mdck
egg
select
investig
ha
gene
sequenc
shown
due
modif
glycosyl
site
area
correspond
antigen
site
b
structur
glycosyl
site
present
virus
isol
mdckcultur
lost
modifi
virus
adapt
growth
egg
recent
antigen
heterogen
influenza
isol
directli
demonstr
electron
microscopi
isol
label
monoclon
antibodi
immunogold
reagent
studi
uniqu
provid
evid
distinct
subpopul
viru
within
singl
strain
report
document
biolog
antigen
heterogen
among
popul
influenza
viru
cultiv
egg
howev
first
time
evid
accumul
strong
select
pressur
antigen
variant
exert
cultiv
virus
egg
probabl
explan
covari
growth
egg
antigen
charact
influenza
b
viru
one
antigen
site
ha
molecul
structur
function
relat
bind
site
cell
surfac
receptor
analysi
influenza
haemagglutinin
indic
epitop
monoclon
antibodi
react
cluster
four
independ
antigen
site
three
dimension
structur
molecul
figur
site
b
appear
topograph
closest
probabl
bind
site
cell
surfac
receptor
regard
relev
influenza
vaccin
pertin
influenza
vaccin
util
virus
cultiv
embryon
hen
egg
howev
serum
antibodi
person
recov
natur
influenza
react
significantli
better
hi
neutral
test
viru
cultiv
mammalian
cell
rather
embryon
hen
egg
therefor
investig
potenti
influenza
vaccin
prepar
mammalian
cell
onaviru
reoviru
vsv
adenoviru
influenza
viru
unpublish
data
see
figur
shown
redistribut
cap
bind
cultur
cell
monolay
cell
maintain
suspens
redistribut
viru
cell
surfac
similar
mani
respect
ligand
induc
tion
membran
receptor
temperatur
energi
depend
block
drug
inhibit
microfila
system
induc
cap
ligand
must
crosslink
receptor
form
two
dimension
matrix
cell
surfac
thu
monoval
fab
antireceptor
antibodi
mediat
cap
sinc
viru
particl
repeat
receptor
bind
subunit
virion
may
regard
multival
ligand
abl
crosslink
receptor
stimul
surfac
redistribut
migrat
cell
surfac
may
facilit
entri
virus
philipson
et
al
suggest
adenoviru
particl
need
contact
bind
receptor
initi
attach
event
intern
proceed
addit
fibrereceptor
contact
consid
brought
later
diffus
receptor
molecul
fluid
membran
bilay
import
multival
viru
later
mobil
membran
receptor
also
emphas
recent
analys
posit
cooper
bind
adenoviru
hela
cell
support
idea
provid
experi
uptak
bound
adenoviru
found
impair
block
unoccupi
receptor
free
adenoviru
fibr
protein
presenc
metabol
inhibitor
cytochalasin
b
membran
receptor
would
free
diffus
howev
condit
uptak
adenoviru
hela
ceil
inhibit
result
may
interpret
two
way
sinc
inhibitor
also
block
surfac
redistribut
may
argu
contact
receptor
achiev
activ
cellmedi
movement
virion
rather
passiv
diffus
receptor
altern
metabolicinhibitor
cytochalasin
b
may
block
pinocyt
intern
event
howev
agent
prevent
entri
influenza
viru
cytoplasm
vacuol
must
rememb
adenoviru
particl
fibr
attach
structur
per
virion
whilst
influenza
estim
ha
spike
per
virion
thu
pinocyt
uptak
mechan
two
virus
may
ident
entri
rout
differ
viru
group
comprehens
review
dale
envelop
virus
enter
fusion
viral
plasma
brane
describ
paramyxovlrus
case
pinocytosi
nonenvelop
virus
adenovirus
also
observ
enter
pinocytosi
addit
uptak
direct
penetr
plasma
membran
describ
mani
envelop
virus
even
abl
fuse
plasma
membran
observ
enter
cell
pinocyticlik
mechan
studi
influenza
viru
shown
uptak
cytoplasm
vacuol
occur
presenc
metabol
cytoskelet
inhibitor
also
evid
intern
influenza
viru
even
subsequ
uncoat
step
occur
find
addit
observ
appar
phagocytosi
sendai
viru
liposom
indic
pinocyt
uptak
envelop
virus
occur
energi
independ
mechan
thermodynam
analysi
bind
polyval
ligand
cell
membran
suggest
bind
induc
curvat
membran
concav
toward
side
ligand
influenza
viru
tightli
pack
haemagglutinin
attach
molecul
may
regard
polyval
ligand
thu
invagin
membran
consequ
viru
attach
may
consid
thermodynam
stabl
configur
membran
adopt
envelop
virus
pinocytos
energi
independ
mechan
uptak
sfv
inhibit
metabol
poison
significantli
affect
cytochalasin
b
possibl
reason
differ
yet
clear
evid
pinocyt
uptak
envelop
virus
occur
special
site
plasma
membran
known
coat
pit
structur
may
concern
uptak
macromolecul
first
propos
subsequ
demonstr
certain
receptor
lowdens
lipoprotein
concentr
coat
pit
receptor
molecul
exampl
local
coat
pit
ligand
bind
ultrastructur
site
recognis
thicken
cytoplasm
side
membran
figur
due
ton
protein
call
clathrin
endocytosi
special
plasma
membran
site
result
format
coat
vesicl
contain
ligandreceptor
complex
nake
endosom
soon
form
dissoci
clathrin
coat
recycl
back
plasma
membran
willingham
colleagu
propos
coat
vesicl
pinch
plasma
membran
remain
connect
via
long
narrow
neck
receptor
bound
ligand
migrat
vesicleneck
junction
bud
uncoat
membran
call
newli
form
vesicl
contain
ligandreceptor
complex
receptosom
uptak
sfv
cytoplasm
vacuol
occur
coat
pit
receptor
viru
concentr
coat
pit
thu
bound
virion
migrat
initi
attach
site
shown
microvilli
bhk
cell
coat
pit
molecular
mechan
mediat
migrat
uncoat
coat
site
appear
differ
oper
cap
experi
c
macroglobulin
shown
cluster
bound
receptor
coat
pit
inhibit
dansylcadaverin
although
precis
mode
action
drug
plasma
membran
unknown
cytochalasin
b
stop
sfv
reach
coat
pit
metabol
inhibitor
prevent
cluster
bound
receptor
site
thu
transport
coat
pit
seem
proceed
via
dansylcadaverinesensit
mechan
independ
cytoskelet
system
insensit
metabol
inhibitor
uptak
cytoplasm
vacuol
viru
still
face
problem
penetr
cellular
membran
releas
nucleic
acid
order
initi
infect
two
line
evid
deriv
origin
studi
influenza
sfv
suggest
fusion
involv
uncoat
process
infect
influenza
viru
depend
posttransl
proteolyt
cleavag
haemagglutinin
molecul
two
compon
term
subunit
link
disulphid
bridg
anchor
viral
membran
carboxytermin
end
find
terminu
highli
conserv
throughout
differ
influenza
serotyp
almost
ident
nh
terminu
sendal
viru
f
fusion
protein
strongli
suggest
mediat
fusion
event
direct
evid
role
fusion
event
come
recent
studi
involv
sitespecif
mutagenesi
cdna
encod
ha
influenza
three
mutant
sequenc
within
first
eleven
amino
acid
gener
incorpor
vector
ha
express
simian
cell
two
mutant
involv
substitut
glutam
acid
glycin
result
either
fusion
activ
rais
thresholdph
reduc
effici
fusion
whilst
extens
hydrophob
region
substitut
glycin
glutam
acid
gave
mutant
protein
fusion
characterist
compar
wild
type
protein
studi
sfv
heleniu
colleagu
observ
virion
enter
via
coat
pit
end
lysosom
parallel
studi
sfv
induc
fuse
plasma
membran
bhk
cell
adsorb
cell
viru
briefli
expos
prepar
warm
medium
ph
addit
lowphdepend
fusion
viru
liposom
demonstr
data
propos
low
ph
environ
lysosom
promot
fusion
viral
lysosom
membran
result
releas
viral
nucleic
acid
cell
cytoplasm
antivir
action
lysosomotrop
agent
chloroquin
amantadin
rais
lysosom
ph
block
viru
infect
earli
stage
prior
transcript
appear
support
hypothesi
work
extend
envelop
virus
includ
vsv
influenza
tm
rabi
pathway
similar
follow
sfv
propos
furthermor
influenza
viru
evid
low
ph
caus
conform
chang
haemagglutinin
molecul
expos
domain
molecul
mediat
fusion
bachi
et
al
vv
prepar
monoclon
anti
ha
antibodi
recognis
intern
viru
viru
adsorb
cell
surfac
bind
antibodi
intern
viru
inhibit
treat
cell
ammonium
chlorid
find
provid
support
hypothesi
conform
chang
ha
initi
fusion
activ
occur
acid
cellular
compart
addit
influenza
viru
recent
evid
envelop
glycoprotein
anoth
viru
la
cross
viru
member
bunyavirida
undergo
conform
chang
ph
fusion
activ
although
evid
fusion
step
uncoat
sever
envelop
virus
quit
strong
number
point
still
requir
clarif
data
fusion
occur
lysosom
indirect
fusion
viral
lysosom
membran
visualis
lysosom
low
ph
compart
within
cell
ph
macrophag
phagocyt
vacuol
endocyt
vacuol
fibroblast
reduc
ph
prior
fusion
lysosom
furthermor
argument
weak
base
block
viru
infect
rais
intralysosom
ph
wholli
convinc
studi
amantadin
shown
antivir
activ
cultur
cell
revers
wash
drugfre
medium
howev
wash
treat
cell
concentr
amantadin
remain
lysosom
compart
still
greater
vaccin
vol
june
requir
extracellular
medium
produc
maximum
antivir
activ
inconsist
chloroquin
inhibit
sindbi
viru
infect
subconflu
bhk
cell
confluent
bhk
cell
aed
albopictu
cell
tm
methylamin
chloroquin
rais
lysosom
ph
similar
extent
yet
latter
tenfold
effect
inhibit
sfv
therefor
data
provid
convinc
evid
lysosom
uncoat
sinc
origin
public
heleniu
cowork
modifi
scheme
uncoat
sfv
shown
uncoat
occur
within
min
entri
passag
lysosom
observ
min
uptak
addit
uncoat
observ
temperatur
low
fusion
endocyt
vacuol
lysosom
acid
prelysosom
vacuol
propos
site
fusion
data
support
similar
endosomalpathway
influenza
viru
also
publish
new
scheme
overcom
mani
critic
rais
although
ha
influenza
viru
mediat
membran
fusion
report
neuraminidas
na
glycoprotein
also
play
role
liposom
contain
ha
na
found
fuse
cell
membran
whilst
liposom
contain
ha
lack
fusion
activ
addit
antina
antibodi
observ
block
virusmedi
lowphdepend
lysi
erythrocyt
ss
howev
cell
express
ha
clone
gene
induc
fuse
low
ph
absenc
na
sinc
antibodi
na
neutral
infect
st
difficult
assess
precis
function
na
uncoat
studi
inhibitori
action
amantadin
shown
two
concentr
depend
effect
ss
level
mm
prevent
fusion
low
ph
rais
endosom
ph
effect
strain
influenza
includ
influenza
b
virus
well
group
envelop
virus
influenza
virus
least
mutat
readili
overcom
effect
high
level
amantadin
mutant
possess
elev
phdepend
ha
conform
chang
requir
fusion
amino
acid
sequenc
threedimension
locat
substitut
ha
determin
shown
fall
two
group
disrupt
intersubunit
contact
ha
trimer
destabil
ph
locat
nh
terminu
specif
effect
observ
amount
amantadin
btm
use
certain
strain
virus
suscept
gene
matrix
protein
appear
play
signific
role
determin
low
dose
resist
drug
l
l
recent
shown
splice
transcript
matrix
gene
rna
segment
code
second
protein
confer
sensit
amantadin
gener
amantadin
resist
mutat
key
region
map
four
amino
acid
hydrophob
region
polypeptid
detect
surfac
infect
cell
yet
found
free
viru
particl
inhibitori
mechan
low
dose
amantadin
sensit
influenza
viru
strain
clear
experi
bukrinskaya
colleagu
suggest
one
possibl
mode
action
employ
amantadin
deriv
rimantadin
tool
studi
influenza
viru
uncoat
nuclear
associ
cytoplasm
separ
infect
cell
analys
densiti
gradient
centrifug
peak
viral
materi
observ
correspond
ribonucleoprotein
rnp
rnp
plu
matrix
respect
former
found
nucleu
haemagglutinin
neuraminidas
detect
either
fraction
examin
fraction
electron
microscopi
reveal
corelik
bodi
appar
helic
presenc
rimantadin
compon
detect
suggest
drug
prevent
dissoci
viral
rnp
matrix
protein
two
step
uncoat
influenza
viru
propos
fusion
endocyt
vesicl
releas
rnpmatrix
complex
cytoplasm
second
rimantadinesensit
step
occur
perinuclear
zone
result
dissoci
matrix
rnp
passag
rnp
nucleu
adenoviru
two
rout
adenoviru
uptak
describ
direct
penetr
plasma
membran
entri
via
pinocyt
vesicl
follow
penetr
vacuolar
membran
thin
section
electron
microscopi
fail
provid
imag
virion
halfway
across
plasma
membran
penetr
may
rapid
event
sinc
limit
proport
plasma
membran
observ
thin
section
chanc
see
penetr
could
low
contrast
examin
adenovirusinfect
kb
cell
freezefractur
techniqu
permit
observ
larg
expans
membran
shown
virion
appar
lodg
bilay
plasma
membran
hennach
et
al
found
destabil
hela
cell
plasma
membran
citrat
buffer
enhanc
attach
adenoviru
without
affect
cell
viabil
sensit
infect
freezefractur
citratetr
cell
adsorb
viru
reveal
protrus
e
fractur
face
plasma
membran
devoid
intramembran
particl
area
observ
uninfect
control
similar
result
also
obtain
treat
cell
adenoviru
fibr
protein
coval
attach
sepharos
bead
intramembran
particlefre
area
rapidli
disappear
warm
tempt
specul
particl
clearanc
facilit
penetr
sinc
clearanc
intramembran
particl
also
observ
oppos
granul
plasma
membran
mast
cell
immedi
prior
fusion
exocytosi
uptak
adenoviru
particl
cytoplasm
vacuol
occur
coat
pit
although
pinocyt
uptak
mao
occur
exclus
site
coat
pit
receptosomeendosom
entri
rout
examin
fitzgerald
et
al
cell
incub
simultan
goldlabel
epiderm
growth
factor
egf
known
enter
via
coat
pit
receptosom
rout
viru
viru
egf
observ
togeth
coat
pit
subsequ
uncoat
receptosomesendosom
later
stage
gold
viru
particl
found
lie
free
cytoplasm
suggest
adenoviru
particl
escap
vacuol
earli
viruscel
interact
patterson
j
oxford
membran
dissolut
view
support
find
effect
pseudomona
toxin
act
cytoplasm
site
enhanc
incub
adenoviru
current
littl
known
adenoviru
compon
mediat
membran
penetr
dissolut
howev
clue
possibl
mechan
provid
investig
svensson
shown
neutral
ph
adenoviru
bound
cell
via
fibr
protein
whilst
low
ph
attach
mediat
penton
base
addit
lysosomotrop
agent
found
caus
partial
inhibit
particl
releas
endosom
find
suggest
one
rout
cytoplasm
entri
depend
low
ph
environ
endosom
sinc
penetr
plasma
membran
also
describ
presum
mechan
cell
infect
radiolabel
adenoviru
disrupt
analys
densiti
gradient
centrifug
techniqu
lonbergholm
philipson
three
subvir
fraction
isol
term
order
increas
densiti
sequenc
appear
c
e
particl
c
fraction
consid
first
intermedi
uncoat
unlik
nativ
viru
sensit
dnaas
consid
due
loss
penton
base
fibr
unit
vertic
analysi
earli
uncoat
intermedi
demonstr
particl
reduc
amount
penton
base
fibr
protein
ms
find
also
correl
less
angular
morpholog
recent
shown
sensit
dnaas
plasma
membran
level
block
edta
egta
dithiothreitol
dansylcadaverin
led
propos
destabil
attach
virion
follow
reorgan
plasma
membran
cytoplasm
nuclear
fraction
obtain
lonbergholm
philipson
experi
yield
particl
sensit
dnaas
c
particl
consid
repres
viral
core
e
subcompon
last
appear
predominantli
nuclear
locat
probabl
repres
free
viral
dna
penetr
cytoplasm
adenoviru
c
particl
transport
nucleu
microtubul
seem
involv
process
sinc
colchicin
microtubul
depolymer
agent
delay
decreas
viru
product
studi
vitro
adenoviru
show
ts
mutant
iru
associ
microtubul
permiss
nonpermiss
temperatur
final
destin
c
particl
nuclear
pore
figur
extrus
viral
nucleoprotein
core
particl
nucleu
occur
histochem
studi
reveal
increas
atpas
activ
nuclear
membran
associ
nuclear
pore
rag
sinc
atpas
inhibitor
phydroxymercuribenzo
prevent
associ
viru
nuclear
pore
propos
extrus
nucleoprotein
nucleu
enerydepend
process
viru
nonpermiss
temperatur
produc
normal
yield
particl
full
complement
viral
protein
howev
three
core
protein
vi
vii
viii
present
uncleav
precursor
form
although
contain
infecti
dna
particl
noninfecti
examin
cell
infect
noninfecti
tsl
progeni
viru
indic
block
late
stage
uncoat
result
accumul
subvir
intermedi
compos
dna
peptid
v
pvii
trace
amount
vii
although
detect
cell
infect
wildtyp
viru
compon
consid
shortliv
intermedi
normal
uncoat
peptid
vi
vii
basic
bind
dna
thought
involv
packag
viral
dna
complet
dissoci
core
protein
dna
uncoat
thu
seem
requir
proper
posttransl
process
previou
investig
suggest
releas
viral
core
occur
within
close
proxim
nuclear
pore
howev
mirza
weber
j
found
much
compon
close
associ
nucleu
therefor
propos
releas
core
also
occur
nonnuclear
associ
site
convers
nativ
viru
modifi
particl
lack
accompani
mark
alter
antigen
properti
thought
reflect
conform
chang
virion
protein
chang
result
exposur
hydrophob
group
sinc
particl
bind
liposom
lonbergholm
whiteley
propos
particl
intercal
plasma
membran
repres
penultim
stage
uncoat
howev
observ
particl
becom
suscept
nucleas
treatment
chymotrypsin
suggest
addit
step
requir
proteas
treatment
also
caus
loss
convert
particl
c
particl
thu
particl
seem
requir
process
cellderiv
proteas
order
releas
rna
detect
particl
lack
infect
cell
support
idea
experi
isol
plasma
membran
indic
loss
occur
plasma
membran
chang
may
also
take
place
entri
sinc
virion
intern
presenc
rhodanin
becom
uncoat
remov
drug
densiti
gradient
fraction
hela
cell
plasma
membran
reveal
four
band
viru
bind
activ
heaviest
band
contain
activ
band
abl
convert
nativ
particl
particl
band
mediat
subsequ
process
c
particl
rather
surprisingli
extract
band
found
inhibit
process
particl
c
particl
band
suggest
inhibitori
fraction
may
prevent
uncoat
arrest
particl
plasma
membran
altern
may
enhanc
infect
delay
second
uncoat
step
entri
cell
although
picornavirus
uncoat
sever
step
outlin
fmdv
provid
except
fmdv
elut
cell
contrast
picornavirus
reattach
show
loss
cell
infect
viru
presenc
low
salt
buffer
viru
disrupt
membran
releas
rna
subunit
although
condit
unphysiolog
may
mirror
event
occur
cellular
entri
sinc
approxim
cellassoci
fmdv
disrupt
subunit
within
rain
entri
intermedi
lack
found
data
suggest
fmdv
uncoat
singl
rather
multistep
process
compar
electron
microscop
studi
mechan
cellular
entri
picornavirus
dunneback
et
al
observ
poliovirus
lie
free
cytoplasm
well
vacuol
two
minut
infect
propos
viru
could
directli
penetr
plasma
membran
idea
compat
data
show
particl
bind
liposom
howev
recent
public
polioviru
uptak
indic
entri
via
coat
pit
endosom
possibl
lysosom
reduc
ph
conform
chang
result
exposur
hydrophob
region
virion
facilit
passag
viral
genom
membran
compar
number
studi
examin
morpholog
interact
virus
cell
much
less
data
publish
immedi
physiolog
effect
interact
although
may
profound
effect
cell
organ
infect
immedi
practic
aspect
includ
possibl
differenti
entri
antivir
compound
viru
infect
cell
compar
normal
cell
lshida
homma
demonstr
uvinactiv
sendai
viru
interact
cell
produc
leakag
certain
phosphoryl
metabolit
phosphatidylcholin
even
though
cell
lyse
slcrlabel
intracellular
compon
leak
pasternak
micklem
hypothesis
leakag
result
incorpor
inher
leaki
viral
envelop
n
cell
plasma
membran
fusion
event
introduc
nonspecif
hydrophil
channel
cell
membran
result
leakag
low
molecular
weight
compound
nucleotid
sugar
phosphat
na
k
ion
cell
extracellular
ca
dival
cation
revers
prevent
leakag
thu
viral
induc
channel
oper
resembl
intercellular
commun
junction
gap
junction
cell
effect
note
particularli
certain
paramyxovirus
although
earli
harvest
viru
unabl
caus
fusion
haemolysi
also
unabl
induc
leaki
cell
membran
cell
specif
note
surpris
sinc
paramyxoviru
receptor
occur
wide
varieti
cell
type
similar
chang
also
note
organ
cultur
carrasco
esteban
describ
earli
h
postinfect
permeabl
chang
cell
membran
induc
vaccinia
viru
exampl
modifi
membran
permit
entri
translat
inhibitor
hygromycin
b
protein
toxin
ctsarcin
adenoviru
infect
also
promot
entri
high
molecular
weight
toxin
cell
ad
chang
permeat
mti
ion
also
occur
later
stage
actual
viru
replic
cell
phenomenon
restrict
paramyxovirus
also
includ
virus
possess
lipid
envelop
late
time
viru
infect
translat
inhibitor
normal
penetr
uninfect
cell
pass
cell
defect
cell
permeabl
would
expect
contribut
cellular
damag
sever
way
exampl
carrasco
argu
increas
intracellular
na
might
contribut
factor
switch
synthesi
host
protein
synthesi
viral
protein
increas
entri
ca
like
advers
consequ
gener
cellular
metabol
whilst
loss
intracellular
nucleotid
especi
atp
cyclic
nucleotid
like
even
damag
cell
tendenc
swell
osmosi
water
entri
normal
prevent
activ
extrus
na
cell
oper
na
pump
pump
malfunct
lack
atp
exampl
surfac
plasma
membran
made
leaki
entri
na
exce
capac
na
pump
remov
net
entri
na
accompani
water
occur
result
cell
swell
lead
cell
lysi
case
erythrocyt
infect
paramyxovirus
influenza
low
ph
wherea
cell
abl
increas
volum
without
ruptur
giant
cell
may
form
conclus
emphas
introduct
brief
review
obviou
throughout
text
studi
earli
interact
virus
cell
date
rather
biolog
often
employ
direct
observ
electron
microscopi
must
recogn
import
pitfal
name
observ
viruscel
interact
may
actual
lead
infect
futur
studi
use
interact
varieti
viral
protein
known
amino
acid
sequenc
possibl
model
virusliposom
system
exampl
lead
rapid
expans
new
detail
knowledg
would
reemphasis
addit
intrins
valu
would
expect
data
use
design
specif
inhibitor
viru
replic
chemoprophylaxi
viru
diseas
also
new
approach
immunoprophylaxi
vaccin
design
encompass
exampl
epitop
induc
antibodi
receptor
site
viru
protein
